ARCA biopharma Inc. (ABIO)

Director Martin Christopher Nathan 🟢 acquired 35.0K shares (1 derivative) of Oruka Therapeutics, Inc. (ORKA) at $30.21 ($1.1M) Transaction Date: Dec 11, 2025 | Filing ID: 000019

Nuvalent Inc (NUVL)

Squarer Ron 🟢 acquired 7.3K shares (1 derivative) of Nuvalent, Inc. (NUVL) at $105.74 Transaction Date: Dec 10, 2025 | Filing ID: 316060